Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S

被引：0
|
作者：
Osoegawa, A. [1 ]
Hashimoto, T. [1 ]
Takumi, Y. [1 ]
Kobayashi, R. [1 ]
Miyawaki, M. [1 ]
Takeuchi, H. [1 ]
Okamoto, T. [1 ]
Sugio, K. [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Yufu, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Acquired resistance; EGFR-TKI; PTEN;
D O I：
10.1016/j.jtho.2017.09.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02-039
引用
下载
收藏
页码：S2251 / S2251
页数：1
相关论文
共 50 条
  • [21] Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
    Cheong, Hio Teng
    Xu, Fei
    Choy, Chi Tung
    Hui, Connie Wun Chun
    Mok, Tony Shu Kam
    Wong, Chi Hang
    ONCOLOGY LETTERS, 2018, 15 (01) : 901 - 907
  • [22] Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
    Lin, Chien-Yu
    Hu, Chia-Hao
    Hsu, Chia-Fu
    Tsai, Jeng-Shiuan
    Chen, Chian-Wei
    Lin, Chia-Yin
    Chang, Chao-Chun
    Yen, Yi-Ting
    Tseng, Yau-Lin
    Su, Po-Lan
    Lin, Chien-Chung
    THORACIC CANCER, 2023, 14 (19) : 1857 - 1864
  • [23] SEVERAL RECEPTOR TYROSINE KINASE IS ACTIVATED BUT ORCHESTRATED BY EGFR IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMA CELLS WITH EGFR MUTATION
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Sato, Katsuaki
    Takemoto, Toshiki
    Iwasaki, Takuya
    Minami, Kenji
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S771 - S772
  • [24] Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review)
    Li, Kaidi
    Yang, Maojun
    Liang, Naixin
    Li, Shanqing
    ONCOLOGY REPORTS, 2017, 37 (03) : 1347 - 1358
  • [25] IRREVERSIBLE EGFR-TKI
    Yang, James C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S439
  • [26] The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
    Lu, S.
    Wang, Q.
    Zhang, G.
    Dong, X.
    Yang, C.
    Song, Y.
    Chang, G.
    Lu, Y.
    Pan, H.
    Chiu, C.
    Wang, Z.
    Feng, J.
    Zhou, J.
    Xu, X.
    Guo, R.
    Chen, J.
    Yang, H.
    Chen, Y.
    Yu, Z.
    Shiah, H.
    Wang, C.
    Yang, N.
    Fang, J.
    Wang, P.
    Wang, K.
    Hu, Y.
    He, J.
    Wang, Z.
    Shi, J.
    Chen, S.
    Cheng, Y.
    Su, W.
    Hsia, T.
    Cui, J.
    Sun, Y.
    Yang, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S208 - S209
  • [27] Overcoming EGFR-TKI resistance in EGFR-mutated lung cancer
    Gardizi, M.
    Scheffler, M.
    Bos, M.
    Geist, T.
    Heukamp, L.
    Nogova, L.
    Toepelt, K.
    Fernandez-Cuesta, L.
    Culmann, H.
    Kaminsky, B.
    Panse, J.
    Becker, C.
    Mattonet, C.
    Serke, M.
    Schmitz, S.
    Schnell, R.
    Galetke, W.
    Hekmat, K.
    Buettner, R.
    Wolf, J.
    ONKOLOGIE, 2013, 36 : 30 - 30
  • [28] EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation
    Koo, Dong-Hoe
    Kim, Kyu-pyo
    Choi, Chang-Min
    Lee, Dae-Ho
    Lee, Jae Cheol
    Lee, Jung-Shin
    Jang, Se Jin
    Kim, Sang-We
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 197 - 206
  • [29] Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
    Uramoto, Hidetaka
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Kuwano, Michihiko
    Ono, Mayumi
    LUNG CANCER, 2011, 73 (03) : 361 - 365
  • [30] EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
    Zhu, Xuan
    Chen, Lijie
    Liu, Ling
    Niu, Xing
    FRONTIERS IN ONCOLOGY, 2019, 9
12345